Centre for Kidney Research and Innovation, University of Nottingham, Nottingham, UK.
Department of Renal Medicine, Royal Derby Hospital, Derby, UK.
Diabetes Obes Metab. 2020 Apr;22 Suppl 1:3-15. doi: 10.1111/dom.14007.
Diabetic nephropathy (DN) is a major healthcare challenge. It occurs in up to 50% of those living with diabetes, is a major cause of end-stage kidney disease (ESKD) that requires treatment with dialysis or renal transplantation, and is associated with significantly increased cardiovascular morbidity and mortality. DN is a clinical syndrome characterized by persistent albuminuria and a progressive decline in renal function, but it is increasingly recognized that the presentation and clinical course of kidney disease in diabetes is heterogeneous. The term diabetic kidney disease (DKD) is now commonly used to encompass the spectrum of people with diabetes who have either albuminuria or reductions in renal function. In this article, the clinical presentation and approach to diagnosis of DKD will be discussed, as will its prognosis. The general principles of management of DKD will also be reviewed with reference to current international guidelines.
糖尿病肾病(DN)是一个主要的医疗保健挑战。它发生在多达 50%的糖尿病患者中,是导致终末期肾病(ESKD)的主要原因,需要进行透析或肾移植治疗,并且与心血管发病率和死亡率的显著增加相关。DN 是一种临床综合征,其特征为持续的白蛋白尿和肾功能进行性下降,但现在越来越多的人认识到糖尿病患者的肾脏疾病的表现和临床过程是异质的。现在,术语“糖尿病肾病(DKD)”通常用于包含患有白蛋白尿或肾功能降低的糖尿病患者。本文将讨论 DKD 的临床表现和诊断方法,以及其预后。还将参考当前的国际指南,回顾 DKD 的一般管理原则。
Diabetes Obes Metab. 2020-4
Nutr Metab Cardiovasc Dis. 2019-10-2
Ther Umsch. 2020-9
Methods Mol Biol. 2020
MMW Fortschr Med. 2005-5-26
J Formos Med Assoc. 2018-3-2
Ren Fail. 2024-12
Front Endocrinol (Lausanne). 2025-7-30
Front Endocrinol (Lausanne). 2025-7-29